Cases & Deals

GRA Venture Fund participates in $25 million Series A financing round of Antios Therapeutics

Clients GRA Venture Fund, LLC and GRA Venture Fund (T.E.), LLC

Jones Day represented GRA Venture Fund in connection with its participation in the $25 million Series A financing round of Antios Therapeutics Inc., an Atlanta, Georgia-based biopharmaceutical company focused on the development of novel antiviral therapies for unmet medical needs.